Our Story:
Why CureGBM
Exists
Sound kills cancer
Jane Oberholzer and her brother Richard founded CureGBM after losing their dad to glioblastoma in 2021—just five weeks after his operation.
3 words for SDT:
Sound kills cancer.
Jane Oberholzer
Gentle. Safe. Non-invasive.
Richard Wakefield
Their vision: one day, SDT could be an outpatient treatment, delivered alongside routine scans—and made as accessible as possible.
We sat down with Aunty M Brain Tumours Talk Show to share our story. Why we started CureGBM. What happened when our dad was diagnosed with glioblastoma in 2021. How we discovered sonodynamic therapy and realized it wasn’t available in Europe. And why we decided to stop waiting and build the pathway ourselves.
In this episode, we share what happened, why we decided to build a company to push progress forward, and the treatment approach we’re working to bring into European trials: sonodynamic therapy (SDT).
The full conversation covers the science behind SDT, how we’re structuring our European clinical trials, and what gives us hope for the future of GBM treatment.
Thank you to Claire (Bullimore) Fayd’Herbe for creating space for these conversations during Brain Tumour Awareness Month.
For every tomorrow
If our story resonates with you, please share this with someone you know.
Help us bring awareness to the urgent need for better brain tumour treatments and faster access to breakthrough therapies.
Be part of the #curegbm family
